Glutathion
Glutathione · GSH
Glutathione is an endogenous tripeptide involved in redox balance. An oral human trial measured changes in glutathione stores.
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
Glutathione (GSH) is the defined tripeptide gamma-glutamyl-cysteinyl-glycine. The oral study formulation does not establish the identity or properties of intravenous products.
- Human research
- Limited
- Replication
- Single research group
- Clinical endpoints
- Surrogate measures
- Safety
- Limited characterization
- Approval
- No documented approval
The dimensions are presented separately and are not combined into an overall score.
What the source shows
54 adults participated in a six-month placebo-controlled trial.
- Oral glutathione: randomized trial of body storesHuman study2015
U.S. National Library of Medicine (PubMed)
Accessed:
Research gaps
- ·Oral findings do not establish benefits of intravenous administration or broad “detox” claims.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
It participates in cellular redox reactions; a changed level is not automatically a clinical benefit.
- Oral glutathione: randomized trial of body storesHuman study2015
U.S. National Library of Medicine (PubMed)
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Safety has not been adequately studied.
Contraindications and warnings
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·Oral findings do not establish benefits of intravenous administration or broad “detox” claims.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- Oral glutathione: randomized trial of body storesHuman study2015
U.S. National Library of Medicine (PubMed)
Accessed:
Sources
Sources checked: · Version 2
- Oral glutathione: randomized trial of body storesHuman study2015
U.S. National Library of Medicine (PubMed)
Accessed: